Chromogranin a and pancreatic polypeptide are not suitable for the screening of pancreatic neuroendocrine tumors in MEN1-a long-term follow-up study

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalEndocrine
Volume89
Issue number3
Pages (from-to)910-920
Number of pages11
ISSN0969-711X
DOIs
Publication statusPublished - Sept 2025
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Chromogranin A
  • Men1
  • Pancreatic neuroendocrine tumor
  • Pancreatic polypeptide
  • Somatostatin receptor PET/CT
  • 3121 General medicine, internal medicine and other clinical medicine

Cite this